New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

ProMIS Neurosciences Inc., a clinical-stage biopharmaceutical company, made significant disclosures in its recent 8-K filing with the Securities and Exchange Commission. In its filing dated January 27 ...